Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice

Neurobiology of Learning and Memory

Volumn 90, Issue 1, 2008, Pages 230-236

  Gulick, Danielle ^a   Gould, Thomas J ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

Acetylcholine; Addiction; Alcohol; Learning; Nicotine; Varenicline

Indexed keywords

ALCOHOL; VARENICLINE;

ALCOHOL ABUSE; ALCOHOL BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; FOOTSHOCK; LEARNING DISORDER; MALE; MOUSE; NONHUMAN;

ACETYLCHOLINE; ALCOHOLISM; ANIMALS; BENZAZEPINES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ETHANOL; FREEZING REACTION, CATALEPTIC; MALE; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; QUINOXALINES; SMOKING CESSATION;

EID: 44649091159     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nlm.2008.03.002     Document Type: Article

References (50)

1. Addy N., Nakajama A., and Levin E. Nicotinic mechanisms of memory: Effects of acute local DHbE and MLA infusions in the basolateral amygdala. Cognitive Brain Research 16 (2003) 51-57
2. Al Qatari M., Bouchenafa O., and Littleton J. Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex. Alcohol Clinical and Experimental Research 22 4 (1998) 810-814
3. Blomqvist O., Ericson M., Johnson D.H., Engel J.A., and Soderpalm B. Voluntary ethanol intake in the rat: Effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment. European Journal of Pharmacology 314 (1996) 257-267
4. Brasser S.M., McCaul M.E., and Houtsmuller E.J. Alcohol effects during acamprosate treatment: A dose-response study in humans. Alcohol Clinical and Experimental Research 28 (2004) 1074-1083
5. Chan W.K., Wong P.T., and Sheu F.S. Frontal cortical alpha7 and alpha4beta2 nicotinic acetylcholine receptors in working and reference memory. Neuropharmacology 52 (2007) 1641-1649
6. Chastain G. Alcohol, neurotransmitter systems, and behavior. Journal of General Psychology 133 (2006) 329-335
7. Coe J.W., Brooks P.R., Vetelino M.G., Wirtz M.C., Arnold E.P., Huang J., et al. Varenicline: An alpha4beta2 nicotinic receptor partial agonist for smoking cessation. Journal of Medicinal Chemistry 48 (2005) 3474-3477
8. Cole S., and McNally G.P. Opioid receptors mediate direct predictive fear learning: Evidence from one-trial blocking. Learning and Memory 14 4 (2007) 229-235
9. Cowen M.S., Adams C., Kraehenbuehl T., Vengeliene V., and Lawrence A.J. The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system. Addiction Biology 10 (2005) 233-242
10. Davis T.J., and de Fiebre C.M. Alcohol's actions on neuronal nicotinic acetylcholine receptors. Alcohol Research and Health 29 (2006) 179-185
11. Davis J.A., and Gould T.J. Beta2 subunit-containing nicotinic receptors mediate the enhancing effect of nicotine on trace cued fear conditioning in C57BL/6 mice. Psychopharmacology (Berlin) 190 (2007) 343-352
12. Davis J.A., Kenney J.W., and Gould T.J. Hippocampal alpha4beta2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning. Journal of Neuroscience 27 (2007) 10870-10877
13. Dawson D.A. Drinking as a risk factor for sustained smoking. Drug and Alcohol Dependence 59 (2000) 235-249
14. Ericson M., Blomqvist O., Engel J.A., and Soderpalm B. Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine. European Journal of Pharmacology 358 (1998) 189-196
15. Feeney G.F., Connor J.P., Young R.M., Tucker J., and McPherson A. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: A single centres' experience with pharmacotherapy. Alcohol and Alcoholism 41 (2006) 321-327
16. Freeman F.M., and Young I.G. Identification of the opioid receptors involved in passive-avoidance learning in the day-old chick during the second wave of neuronal activity. Brain Research 864 (2000) 230-239
17. Funk D., Marinelli P.W., and Le A.D. Biological processes underlying co-use of alcohol and nicotine: Neuronal mechanisms, cross-tolerance, and genetic factors. Alcohol Research and Health 29 (2006) 186-192
18. Gould T.J. Ethanol disrupts fear conditioning in C57BL/6 mice. Journal of Psychopharmacology 17 (2003) 77-81
19. Gould T.J. Nicotine and hippocampus-dependent learning: Implications for addiction. Molecular Neurobiology 34 (2006) 93-107
20. Gould T.J., and Stephen Higgins J. Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training. Neurobiology of Learning and Memory 80 (2003) 147-157
21. Gould T.J., and Lommock J.A. Nicotine enhances contextual fear conditioning and ameliorates ethanol-induced deficits in contextual fear conditioning. Behavioral Neuroscience 117 (2003) 1276-1282
22. Gould T.J., and Wehner J.M. Nicotine enhancement of contextual fear conditioning. Behavioral Brain Research 102 (1999) 31-39
23. Gulick D., and Gould T.J. Acute ethanol has biphasic effects on short- and long-term memory in both foreground and background contextual fear conditioning in C57BL/6 mice. Alcohol Clinical and Experimental Research 31 (2007) 1528-1537
24. Han Z.Y., Zoli M., Cardona A., Bourgeois J.P., Changeux J.P., and Le Novere N. Localization of [3H]Nicotine, [3H]Cytisine, [3H]Epibatidine, and [125I]_-Bungarotoxin Binding Sites in the Brain of Macaca mulatta. Journal of Comparative Neurology 461 (2003) 49-60
25. Jerlhag E., Grotli M., Luthman K., Svensson L., and Engel J.A. Role of the subunit composition of central nicotinic acetylcholine receptors for the stimulatory and dopamine-enhancing effects of ethanol. Alcohol and Alcoholism 41 (2006) 486-493
26. John U., Meyer C., Rumpf H.J., and Hake U. Probabilities of alcohol high-risk drinking, abuse, or dependence estimated on grounds of tobacco smoking and nicotine dependence. Addiction 98 (2003) 805-814
27. Larsson A., and Engel J.A. Neurochemical and behavioral studies on ethanol and nicotine interactions. Neuroscience and Biobehavioral Reviews 27 (2004) 713-720
28. Le A.D., Corrigall W.A., Harding J.W., Juzytsch W., and Li T.K. Involvement of nicotinic receptors in alcohol self-administration. Alcohol Clinical and Experimental Research 24 (2000) 155-163
29. Logue S.F., Paylor R., and Wehner J.M. Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task. Behavioral Neuroscience 111 (1997) 104-113
30. Marks M.J., Whiteaker P., and Collins A.C. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine. Molecular Pharmacology 70 3 (2006) 947-959
31. McCaul M.E., Wand G.S., Eissenberg T., Rohde C.A., and Cheskin L.J. Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects. Neuropsychopharmacology 22 (2000) 480-492
32. Melia K.R., Ryabinin A.E., Corodimas K.P., Wilson M.C., and Ledoux J.E. Hippocampal-dependent learning and experience-dependent activation of the hippocampus are preferentially disrupted by ethanol. Neuroscience 74 (1996) 313-322
33. Mihalak K.B., Carroll F.I., and Luetje C.W. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Molecular Pharmacology 70 (2006) 801-805
34. Mikolajczak P., Okulicz-Kozaryn I., Kaminska E., Niedopad L., Polanska A., and Gebka J. Effects of acamprosate and some polyamine site ligands of NMDA receptor on short-term memory in rats. European Journal of Pharmacology 444 (2002) 83-96
35. Nava F., Premi S., Manzato E., and Lucchini A. Comparing treatments of alcoholism on craving and biochemical measures of alcohol consumptions. Journal on Psychoactive Drugs 38 (2006) 211-217
36. Okulicz-Kozaryn I., Midolajczak P., Szczawinska K., Kaminska E., and Kus K. Effects of acamprosate and scopolamine on the working memory of rats in a three-panel runway task. Journal of Basic Clinical Physiology and Pharmacology 12 (2001) 197-216
37. Phillips R.G., and LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behavioral Neuroscience 106 (1992) 274-285
38. Picciotto M. Nicotine as a modulator of behavior: Beyond the inverted U. Trends in Pharmacological Sciences 24 9 (2003) 493-499
39. Rollema H., Coe J.W., Chambers L.K., Hurst R.S., Stahl S.M., and Williams K.E. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Trends in Pharmacological Sciences 28 (2007) 316-325
40. Rollema H., Chambers L.K., Coe J.W., Glowa J., Hurst R.S., Lebel L.A., et al. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52 (2007) 985-994
41. Schneider U., Wohlfarth K., Schulze-Bonhage A., Haacker T., Muller-Vahl K.R., Zedler M., et al. Effects of acamprosate on memory in healthy young subjects. Journal of Studies on Alcohol 60 (1999) 172-175
42. Séguéla P., Wadiche J., Dineley-MIller K., Dani J.A., and Patrick J.W. Molecular cloning, functional properties and distribution of rat brain a7: A nicotinic cation channel highly permeable to calcium. Journal of Neuroscience 13 (1993) 596-604
43. Silva R.H., and Frussa-Filho R. Naltrexone potentiates both amnestic and anxiolytic effects of chlordiazepoxide in mice. Life Sciences 72 6 (2002) 721-730
44. Steensland P., Simms J.A., Holgate J., Richards J.K., and Bartlett S.E. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proceedings of the National Academy of Sciences of the United States of America 104 (2007) 12518-12523
45. Stromberg M.F., Mackler S.A., Volpicelli J.R., and O'Brien C.P. Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption. Alcohol 23 (2001) 109-116
46. Sweatt J.D. Toward a molecular explanation for long-term potentiation. Learning and Memory 6 (1999) 399-416
47. Tennant Jr. F.S., Tarver A.L., and Rawson R.A. Clinical evaluation of mecamylamine for withdrawal from nicotine dependence. NIDA Research Monograph 49 (1984) 239-246
48. Wada E., Wada K., Boutler J., Deneris E., Heinemann S., Patrick J., and Swanson L. Distribution of alpha 2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridisation histochemical study in the rat. Journal of Computational Neurology 284 (1989) 314-335
49. Walters C.L., Brown S., Changeux J.P., Martin B., and Damaj M.I. The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berlin) 184 (2006) 339-344
50. Wehner J.M., Keller J.J., Keller A.B., Picciotto M.R., Paylor R., Booker T.K., et al. Role of neuronal nicotinic receptors in the effects of nicotine and ethanol on contextual fear conditioning. Neuroscience 129 (2004) 11-24